Author

Mingyao Meng

Yan'an Hospital Affiliated To Kunming Medical UniversityORCID 0000-0002-9766-414XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Assay:proteomics· 1

Frequent Co-Authors

Qinggang Hao· 3 shared Weiyu BaiiD· 2 shared Chenghao YaniD· 1 shared Haiyan Guo· 1 shared Hayam HamdyiD· 1 shared Jia Hui YuiD· 1 shared Jianwei SuniD· 1 shared Jianwei SuniD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Qinggang Hao

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 29, 2026

Single-cell profiling reveals MMP7-associated epithelial transition and immune-stromal remodeling in esophageal carcinogenesis

Qi Wang, Peng Li, Li Fu…·Yangfan Guo

This study uses single-cell transcriptomics to identify MMP7-associated epithelial transitions and immune-stromal changes in esophageal carcinogenesis.

DOI 10.64898/2026.07.28.741095

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologyScience China Life SciencesPeer-reviewedMay 8, 2025

VPS35/Retromer-dependent MT1-MMP regulation confers melanoma metastasis

Qinggang Hao, Yan Bai, Ruiqi Guan…·Jianwei Sun

This study identifies VPS35/retromer as a regulator of MT1-MMP localization and stability, showing its role in melanoma metastasis and suggesting it as a therapeutic target.

5 citations

humanexperimental assay

𝕏 PostBluesky

Cancer BiologyFEBS JournalPeer-reviewedSep 19, 2024

The EGF/EGFR-YAP1/TEAD2 axis-mediated BRAF inhibitor vemurafenib resistance upregulates STIM1 in melanoma

Weiyu Bai, Chenghao Yan, Yichen Yang…·Jianwei Sun

This study identifies the EGF/EGFR-YAP1/TEAD2 axis as a mechanism by which vemurafenib resistance upregulates STIM1 in melanoma.

19 citations

humanproteomics

𝕏 PostBluesky